Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

1. Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy

Hepatitis B Virus Screening and Management for Patients with Cancer Prior to Therapy Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update | Journal of Clinical Oncology Search in: Menu > > > > Article Tools ASCO SPECIAL ARTICLES Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.20.01757 Journal of Clinical Oncology - published online before print July 27, 2020 PMID (...) : Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update , MD, MPH 1 x Jessica P. Hwang ; , MD, MPH 2 x Jordan J. Feld ; , MD 3 x Sarah P. Hammond ; , MD, MPH 4 x Su H. Wang ; , MD, MMM 5 x Devena E. Alston-Johnson ; , JD 6 x Donna R. Cryer ; , MD 7 x Dawn L. Hershman ; , MD, MPH 8 x Andrew P. Loehrer ; , MD 9 x Anita L. Sabichi ; , MD, MACP 10 x Banu E. Symington ; , MD, MPH 11 x Norah Terrault ; , MD, MAS 12 x Melisa L. Wong ; , PhD

2020 American Society of Clinical Oncology Guidelines

2. Breast screening: IMS Giotto Class evaluation

Breast screening: IMS Giotto Class evaluation Breast screening: IMS Giotto Class evaluation - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: IMS Giotto Class evaluation A evaluation of the IMS Giotto Class Full Field Digital Mammography (...) (FFDM), Digital Breast Tomosynthesis (DBT) and the biopsy facility. Published 12 August 2020 From: Documents If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document presents a practical evaluation of the IMS Giotto Class Explore the topic Is this page useful? Thank you for your feedback Help us

2020 Public Health England

3. Breast screening: Siemens Mammomat Revelation evaluation

Breast screening: Siemens Mammomat Revelation evaluation Breast screening: Siemens Mammomat Revelation evaluation - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: Siemens Mammomat Revelation evaluation An evaluation of the Siemens Mammomat (...) Revelation system for use in the NHS Breast Screening Programme (BSP). Published 12 August 2020 From: Documents If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document presents an evaluation of the Siemens Mammomat Revelation system for use in the NHS Explore the topic Is this page useful? Thank you

2020 Public Health England

4. Breast screening: Hologic 3Dimensions in tomosynthesis mode

Breast screening: Hologic 3Dimensions in tomosynthesis mode Breast screening: Hologic 3Dimensions in tomosynthesis mode - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: Hologic 3Dimensions in tomosynthesis mode A practical evaluation

2020 Public Health England

5. Diabetic eye screening: identifying differences in grading outcomes

Diabetic eye screening: identifying differences in grading outcomes Diabetic eye screening: identifying differences in grading outcomes - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Diabetic eye screening: identifying differences in grading outcomes (...) Quality assurance method used to compare grading outcomes between local diabetic eye screening providers. Published 7 June 2019 Last updated 28 July 2020 — From: Documents Ref: GW-1421 HTML Details This publication describes the statistical method used to compare grading outcomes between local NHS diabetic eye screening ( with any queries about this publication, making sure you include its full title. Published 7 June 2019 Last updated 28 July 2020 28 July 2020 Updated guidance on implementation

2020 Public Health England

6. NHS population screening: a health equity audit guide

NHS population screening: a health equity audit guide NHS population screening: a health equity audit guide - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance NHS population screening: a health equity audit guide Guidance for screening providers

2020 Public Health England

7. Abdominal aorta aneurysm (AAA) screening of men aged 65

Abdominal aorta aneurysm (AAA) screening of men aged 65 Abdominal aorta aneurysm (AAA) screening of men aged 65 - NIPH Search for: Søk Menu To top level Close Infectious diseases & Vaccines Mental & Physical health Environment & Lifestyle Health in Norway Quality & Knowledge Research & Access to data About NIPH Close Abdominal aorta aneurysm (AAA) screening of men aged 65 Order Download: Key message Abdominal aortic aneurysm (AAA) is a weakening of the aortic wall resulting in an abnormal (...) %. In Norway, it is estimated to be around 2.5%. Prevalence among women is one-sixth to one-fourth of that among men. Screening programs for AAA can help to identify patients with a high risk of AAA rupture. Those identified as suitable for repair, usually by ultrasound scan, are offered preventive (elective) surgery to reduce their individual risk of rupture. In Norway, the number of operations (urgent and elective) is approximately 700-800 per year. AAA screening is considered a potentially beneficial

2020 Norwegian Institute of Public Health

8. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review Full Text available with Trip Pro

AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review - Gastroenterology Go search This Journal Search AGA Journals , P358-362, July 01, 2020 Powered By Mendeley Share on AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review Harry R. Aslanian Correspondence Correspondence Address correspondence to: Harry R (...) for screening for pancreas cancer in high-risk individuals. Methods The evidence reviewed in this work is based on reports of pancreas cancer screening studies in high-risk individuals and expert opinion. Best Practice Advice 1 Pancreas cancer screening should be considered in patients determined to be at high risk, including first-degree relatives of patients with pancreas cancer with at least 2 affected genetically related relatives. Best Practice Advice 2 Pancreas cancer screening should be considered

2020 American Gastroenterological Association Institute

9. Covid-19: Evidence summary for non-contact thermal screening

Covid-19: Evidence summary for non-contact thermal screening Evidence summary for non-contact thermal screening Health Information and Quality Authority Page 1 of 36 Evidence summary for non-contact thermal screening as an effective means of identifying cases of COVID- 19 06 August 2020 Evidence summary for non-contact thermal screening Health Information and Quality Authority Page 2 of 36 Evidence summary for non-contact thermal screening as an effective means of identifying cases of COVID-19 (...) Key points ? Thermal screening, typically including a combination of fever screening with the self-report of exposure risk and or symptoms, has been used in infectious disease outbreaks with the aim of improving detection and reducing the time to isolation for infected individuals. ? Thermal screening is only effective in the identification of febrile symptomatic cases. However, not all cases of COVID-19 present with fever and a substantial proportion are asymptomatic (never symptomatic

2020 Health Information and Quality Authority

10. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to info Full Text available with Trip Pro

Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to info Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview (...) file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Review Syst Rev Actions . 2020 Jan 29;9(1):20. doi: 10.1186/s13643-020-1275-2. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline

2020 EvidenceUpdates

11. Screening for Secondary Solid Malignancies after Stem Cell Transplant

Screening for Secondary Solid Malignancies after Stem Cell Transplant July 2020 Screening for Secondary Solid Malignancies After Stem Cell Transplantation These recommendations were developed by the Stem Cell Transplant Survivorship Community of Practice, under the direction of Cancer Care Ontario’s Stem Cell Transplant Advisory Committee. Introduction The risk for people who have undergone a Stem Cell Transplant (SCT) to develop a secondary solid malignancy is estimated to be as much as two (...) to five times more than the general population, with gender, age, and geographic area adjusted rates taken in to account (1-6). The most common sites affected are the oral cavity and pharynx, bones, soft tissues, liver, thyroid, central nervous system and skin. A crucial component of long-term follow-up care of SCT survivors includes surveillance and screening for the development of secondary solid-tumor cancers by the patient’s Primary Care Provider in addition to their annual post-SCT Long-Term

2020 Cancer Care Ontario

12. Practice Bulletin #226, Screening for Chromosomal Abnormalities

Practice Bulletin #226, Screening for Chromosomal Abnormalities Publications & Guidelines | SMFM.org - The Society for Maternal-Fetal Medicine Navigate | Search Search » » Practice Bulletin #226, Screening for Chromosomal Abnormalities Practice Bulletin #226, Screening for Chromosomal Abnormalities Tags: Categories: © 2000-2020, Society for Maternal-Fetal Medicine. All rights reserved The Pregnancy Meeting is a Trademark of the Society for Maternal-Fetal Medicine. Use of this Web site

2020 Society for Maternal-Fetal Medicine

13. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care

An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public (...) new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Am J Prev Med Actions . 2020 Jul;59(1):41-48. doi: 10.1016/j.amepre.2020.02.014. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care , , , , , Affiliations Expand Affiliations 1 Corporal

2020 EvidenceUpdates

14. Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia

Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Gastroenterology Actions . 2020 Jun;158(8):2082-2092. doi: 10.1053/j.gastro.2020.02.037. Epub 2020 Feb 29. Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus

2020 EvidenceUpdates

15. Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C)

Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C) Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C) - PubMed This site needs (...) Permalink Copy Page navigation Am J Gastroenterol Actions . 2020 Aug;115(8):1264-1274. doi: 10.14309/ajg.0000000000000624. Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C) , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Office of Cancer Screening, National Cancer Center

2020 EvidenceUpdates

16. Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease Full Text available with Trip Pro

Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get (...) there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation CMAJ Actions . 2020 Jul 6;192(27):E768-E777. doi: 10.1503/cmaj.190814. Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease , , , , , , , Affiliations Expand Affiliation 1

2020 EvidenceUpdates

17. Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial

Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC (...) Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Neurology Actions . 2020 Jul 21;95(3):e239-e246. doi: 10.1212/WNL.0000000000009880. Epub 2020 Jun 29. Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial , , , , , , , , , , , , , Affiliations Expand Affiliations 1

2020 EvidenceUpdates

18. Lung Cancer Screening with Low-Dose CT: a Meta-Analysis

Lung Cancer Screening with Low-Dose CT: a Meta-Analysis Lung Cancer Screening with Low-Dose CT: a Meta-Analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: . Get the latest research from NIH: . Find NCBI SARS-CoV-2 literature (...) management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Review J Gen Intern Med Actions . 2020 Jun 24. doi: 10.1007/s11606-020-05951-7. Online ahead of print. Lung Cancer Screening with Low-Dose CT: a Meta-Analysis , , , Affiliations Expand Affiliations 1 University of Iowa Carver College of Medicine, Iowa City, IA, USA. richard-m-hoffman@uiowa.edu. 2 Holden Comprehensive Cancer

2020 EvidenceUpdates

19. Diabetic eye screening: optical coherence tomography in surveillance

Diabetic eye screening: optical coherence tomography in surveillance Diabetic eye screening: optical coherence tomography in surveillance - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Diabetic eye screening: optical coherence tomography in surveillance (...) Guidance for diabetic eye screening providers on use of optical coherence tomography (OCT) in surveillance clinics. Published 8 July 2020 From: Documents Ref: PHE publications gateway number GW-1385 HTML Ref: PHE publications gateway number GW-1385 HTML Ref: PHE publications gateway number GW-1385 HTML Details This document provides consistent best practice guidance for diabetic eye screening ( with any queries about this publication, making sure you include its full title. Published 8 July 2020

2020 Public Health England

20. Fetal anomaly screening: care pathways

Fetal anomaly screening: care pathways Fetal anomaly screening: care pathways - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Fetal anomaly screening: care pathways These documents describe the fetal anomaly screening programme (FASP) pathways. Published 1

2020 Public Health England